News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
861,706 Results
Type
Article (87478)
Company Profile (806)
Press Release (773400)
Multimedia
Podcasts (175)
Webinars (28)
Section
Business (233071)
Career Advice (4140)
Deals (39800)
Drug Delivery (138)
Drug Development (91265)
Employer Resources (203)
FDA (18289)
Job Trends (17403)
News (397435)
Policy (39927)
Tag
Academia (3005)
Academic (2)
Accelerated approval (18)
Adcomms (35)
Allergies (127)
Alliances (56980)
ALS (147)
Alzheimer's disease (1686)
Antibody-drug conjugate (ADC) (257)
Approvals (18323)
Artificial intelligence (501)
Autoimmune disease (88)
Automation (27)
Bankruptcy (406)
Best Places to Work (12633)
BIOSECURE Act (23)
Biosimilars (163)
Biotechnology (485)
Bladder cancer (136)
Brain cancer (53)
Breast cancer (514)
Cancer (4063)
Cardiovascular disease (351)
Career advice (3560)
Career pathing (38)
CAR-T (250)
CDC (57)
Cell therapy (693)
Cervical cancer (33)
Clinical research (75669)
Collaboration (1418)
Company closure (4)
Compensation (942)
Complete response letters (60)
COVID-19 (2960)
CRISPR (82)
C-suite (608)
Cystic fibrosis (140)
Data (4695)
Decentralized trials (2)
Denatured (63)
Depression (112)
Diabetes (459)
Diagnostics (7099)
Digital health (37)
Diversity (11)
Diversity, equity & inclusion (49)
Drug discovery (239)
Drug pricing (191)
Drug shortages (36)
Duchenne muscular dystrophy (205)
Earnings (98926)
Editorial (54)
Employer branding (25)
Employer resources (172)
Events (133174)
Executive appointments (996)
FDA (20807)
Fibrodysplasia Ossificans Progressiva (3)
Friedreich's ataxia (6)
Frontotemporal dementia (16)
Funding (1279)
Gene editing (175)
Generative AI (50)
Gene therapy (554)
GLP-1 (1026)
Government (5387)
Grass and pollen (7)
Guidances (353)
Healthcare (20938)
HIV (48)
Huntington's disease (40)
IgA nephropathy (64)
Immunology and inflammation (245)
Immuno-oncology (21)
Indications (55)
Infectious disease (3209)
Inflammatory bowel disease (191)
Inflation Reduction Act (16)
Influenza (102)
Intellectual property (193)
Interviews (816)
IPO (17928)
IRA (59)
Job creations (5197)
Job search strategy (2865)
Kidney cancer (17)
Labor market (80)
Layoffs (641)
Leadership (36)
Legal (10148)
Liver cancer (92)
Longevity (13)
Lung cancer (584)
Lymphoma (268)
Machine learning (31)
Management (66)
Manufacturing (650)
MASH (143)
Medical device (14890)
Medtech (14915)
Mergers & acquisitions (22763)
Metabolic disorders (1171)
Multiple sclerosis (139)
NASH (23)
Neurodegenerative disease (233)
Neuropsychiatric disorders (63)
Neuroscience (2740)
NextGen: Class of 2025 (7687)
Non-profit (5096)
Now hiring (59)
Obesity (564)
Opinion (315)
Ovarian cancer (137)
Pain (170)
Pancreatic cancer (176)
Parkinson's disease (244)
Partnered (30)
Patents (424)
Patient recruitment (326)
Peanut (57)
People (66308)
Pharmaceutical (145)
Pharmacy benefit managers (27)
Phase I (23342)
Phase II (32840)
Phase III (24756)
Pipeline (2766)
Policy (296)
Postmarket research (3554)
Preclinical (10532)
Press Release (72)
Prostate cancer (204)
Psychedelics (52)
Radiopharmaceuticals (282)
Rare diseases (687)
Real estate (7422)
Recruiting (79)
Regulatory (28071)
Reports (65)
Research institute (2693)
Resumes & cover letters (651)
Rett syndrome (16)
RNA editing (15)
RSV (76)
Schizophrenia (138)
Series A (212)
Series B (158)
Service/supplier (30)
Sickle cell disease (81)
Special edition (26)
Spinal muscular atrophy (170)
Sponsored (41)
Startups (4319)
State (2)
Stomach cancer (17)
Supply chain (101)
Tariffs (96)
The Weekly (110)
Vaccines (1057)
Venture capital (67)
Weight loss (399)
Women's health (60)
Worklife (21)
Date
Today (173)
Last 7 days (742)
Last 30 days (2780)
Last 365 days (33610)
2025 (27242)
2024 (38142)
2023 (42568)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1280)
Alabama (80)
Alaska (7)
Arizona (307)
Arkansas (14)
Asia (51022)
Australia (8967)
California (9623)
Canada (2892)
China (922)
Colorado (406)
Connecticut (429)
Delaware (275)
Europe (117217)
Florida (1415)
Georgia (318)
Hawaii (3)
Idaho (67)
Illinois (819)
India (54)
Indiana (473)
Iowa (20)
Japan (330)
Kansas (125)
Kentucky (38)
Louisiana (22)
Maine (78)
Maryland (1291)
Massachusetts (7213)
Michigan (316)
Minnesota (569)
Mississippi (4)
Missouri (122)
Montana (33)
Nebraska (26)
Nevada (109)
New Hampshire (79)
New Jersey (2674)
New Mexico (32)
New York (2613)
North Carolina (1421)
North Dakota (10)
Northern California (4388)
Ohio (302)
Oklahoma (22)
Oregon (51)
Pennsylvania (1998)
Puerto Rico (19)
Rhode Island (46)
South America (1655)
South Carolina (50)
South Dakota (1)
Southern California (3670)
Tennessee (150)
Texas (1515)
United States (35488)
Utah (285)
Virginia (250)
Washington D.C. (84)
Washington State (826)
West Virginia (4)
Wisconsin (98)
Wyoming (1)
There are 861,706 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Opinion
A Flu Season in Flux Presents Risks, Opportunities for Biopharma
The coming flu season is the clearest indication yet that biopharma’s long-standing assumptions about predictability, prevention and portfolio structure are no longer guaranteed.
October 28, 2025
·
7 min read
·
Tom Sebok
Press Releases
Novartis announces expiration of Tourmaline Bio tender offer
October 28, 2025
·
5 min read
Press Releases
Novartis delivers solid sales and core operating income growth with strong pipeline progress in Q3; reaffirms FY 2025 guidance
October 28, 2025
·
21 min read
Press Releases
Press release: Sanofi successfully prices USD 3 billion of bond issue
October 28, 2025
·
9 min read
Press Releases
Positive phase III results for Roche’s Gazyva/Gazyvaro in children and young adults with idiopathic nephrotic syndrome
October 28, 2025
·
9 min read
Press Releases
Kyowa Kirin and Orchard Therapeutics Announce OTL-200 Granted Orphan Regenerative Medicine Product Designation for Early-onset MLD in Japan
October 28, 2025
·
6 min read
Press Releases
Swarm Oncology announces research collaboration with a leading hospital to advance T cell therapies for advanced solid cancers
October 28, 2025
·
2 min read
Press Releases
BioCina Announces Appointment of Dr. Thomas Broudy as Chief Executive Officer
October 28, 2025
·
4 min read
Press Releases
Samsung Biologics reports third quarter 2025 financial results
October 28, 2025
·
4 min read
Press Releases
Bavarian Nordic Provides Further Support to Mpox Outbreak in Africa through Additional Donation of Vaccines
October 28, 2025
·
2 min read
1 of 86,171
Next
